| 000 | 01694cam a2200265Ii 4500 | ||
|---|---|---|---|
| 001 | 9780429126390 | ||
| 008 | 180331s2005 flua ob 001 0 eng d | ||
| 020 |
_a9780429126390 _q(e-book : PDF) |
||
| 020 |
_z9780849330254 _q(hardback) |
||
| 024 | 7 |
_a10.1201/9781420037890 _2doi |
|
| 035 | _a(OCoLC)70274033 | ||
| 050 | 4 |
_aQP623.5.C36 _bS966 2005 |
|
| 082 | 0 | 4 |
_a572.8 _bS993 |
| 245 | 0 | 0 |
_aSynthetic nucleic acids as inhibitors of gene expression : _bmechanisms, applications, and therapeutics implications / _cedited by Levon Michael Khachigian. |
| 264 | 1 |
_aBoca Raton : _bCRC Press, _c2005. |
|
| 300 | _a1 online resource (182 pages) | ||
| 505 | 0 | _achapter 1 1 -- chapter 2 Development of Ribozymes as Cancer Therapeutics -- chapter 3 RNA Interference: A Technology Based on an Ancient Gene Silencing Pathway -- chapter 4 RNA-Cleaving DNA Enzymes in Gene Silencing: Room for Improvement? -- chapter 5 Deoxyribozymes and Medical Innovation -- chapter 6 Effect of Modifications on the Intracellular Activity of a DNA Enzyme -- chapter 7 Potential Therapeutic Applications of DNA Enzymes and siRNAs against Viral and Cellular Genes -- chapter 8 Use of DNAzymes for Target Gene Validation -- chapter 9 DNAzymes Targeting Immediate-Early Genes as Inhibitors of Angiogenesis and Restenosis -- chapter 10 Decoy Oligodeoxynucleotides as Viable Pharmaceutical Drugs. | |
| 650 | 0 |
_aCatalytic RNA. _918759 |
|
| 650 | 0 |
_aRepressors, Genetic. _918760 |
|
| 650 | 0 |
_aGenetic regulation. _914069 |
|
| 700 | 1 |
_aKhachigian, Levon. _918761 |
|
| 776 | 0 | 8 |
_iPrint version: _z9780849330254 _w(DLC) 2004054474 |
| 856 | 4 | 0 |
_uhttps://www.taylorfrancis.com/books/9781420037890 _zClick here to view. |
| 942 | _cEBK | ||
| 999 |
_c71904 _d71904 |
||